IRME · As filed with the SEC
IR-Med balance sheet, by quarter
The statement as IR-Med presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Interim Condensed Consolidated Balance Sheets (Unaudited) · USD thousands
| USD thousands | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 |
|---|---|---|---|---|
| Assets | ||||
| Current assets | ||||
| Cash and Cash Equivalents | 63 | 51 | 129 | 392 |
| Accounts Receivable | 27 | 30 | 76 | 51 |
| Total current assets | 90 | 81 | 205 | 443 |
| Non- current assets | ||||
| Long term restricted deposit | — | — | — | 11 |
| Long-Term Investments | — | — | 11 | — |
| Restricted Cash, Non-Current | 11 | 11 | — | — |
| Operating Lease Right-of-Use Asset | 45 | — | — | 40 |
| Property, Plant and Equipment | 29 | 32 | 35 | 39 |
| Total non-current assets | 85 | 43 | 46 | 90 |
| Total assets | 175 | 124 | 251 | 533 |
| Liabilities and Stockholders’ equity | ||||
| Current liabilities | ||||
| Accounts Payable | 393 | 428 | 388 | 376 |
| Deferred grant income | 173 | — | — | — |
| Short-Term Debt | 176 | 158 | 157 | — |
| Short-Term Debt | 32 | 31 | — | — |
| Total Current Liabilities | 774 | 617 | 545 | — |
| Non-current liabilities | ||||
| Stockholders’ loans | — | — | — | 155 |
| Operating Lease Liability, Non-Current | 26 | — | — | — |
| Total Non-Current Liabilities | 26 | — | — | — |
| Total liabilities | 800 | 617 | 545 | 531 |
| Stockholders’ deficit | ||||
| Total Stockholders' Equity | 77 | 72 | 70 | 70 |
| Additional Paid-In Capital | 17,510 | 16,946 | 16,374 | 16,392 |
| Retained Earnings | (18,212) | (17,511) | (16,738) | (16,460) |
| Total Stockholders’ deficit | (625) | (493) | (294) | 2 |
| Total liabilities and stockholders’ deficit | 175 | 124 | 251 | 533 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.